| Three Months Ended July 31, | Six Months Ended July 31, | ||||||||||||||
|
2022
|
2021
|
2022
|
2021
| ||||||||||||
| (unaudited, in thousands) | |||||||||||||||
| Stock-based compensation: | |||||||||||||||
| Cost of revenue | $ | 362 | $ | 359 | $ | 711 | $ | 682 | |||||||
| Research and development | 17,883 | 11,525 | 35,034 | 22,719 | |||||||||||
| Selling, general and administrative | 8,664 | 7,488 | 18,205 | 14,813 | |||||||||||
| Total stock-based compensation | $ | 26,909 | $ | 19,372 | $ | 53,950 | $ | 38,214 | |||||||
Ambarella, Inc. Announces Second Quarter Fiscal Year 2023 Financial Results
 |  | More IC News
|
|
The following tables present details of stock-based compensation and acquisition-related costs included in each functional line item in the condensed consolidated statements of operations above:
RELATED NEWS
